(PharmaNewsWire.Com, October 01, 2018 ) Overview: In the year 2018, Europe Antivenom Market was valued at USD 0.3 Billion. By the year 2023, it is expected to reach USD 0.41 Billion at pace of 5.21% CAGR.
Anti-venom is a drug used primarily to treat snake bites and can also be used to treat scorpion, spider or other reptilian bites. It consists of hyperimmune globulins and other proteins extracted from the serum of several animals. These products are available in lyophilized or liquid form. Toxic bites cause clinical conditions such as excessive secretion of saliva, muscle weakness, breathing problems and other difficulties that can also lead to death.
Underlying Causes The growth for Antivenom Market is driven due to factors like increasing incidence of snake bites, rising focus to develop effective antivenom products, and growing awareness about antivenom products among people. In addition, increasing invesments for R&D activities, advancement of technologies in biotechnology and other pharma industries, and availability of well-established healthcare facilities are expected to drive the market growth. However, high cost of the products, limited availability of antivenom products, and stringent regulatory policies are restraining factors which is expected to hinder the growth rate for Europe Antivenom Market during the forecast period.
Geographic Segmentation: Based on geography the Europe Antivenom Market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Europe is expected to have a steady growth rate for Antivenom Market during the forecast period.
Key Players: Leading companies for Europe Antivenom Market are Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
About MarketDataForecast™ Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact Information: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank Filmnagar Branch, B 44, Rd Number 3, Journalist Colony, Hyderabad, Telangana 500033. Phone: +1-888-702-9626
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
